Carboxyhemoglobin predicts oxygenator performance and imminent oxygenator change in extracorporeal membrane oxygenation.

Blood gas analysis Co-oximetry Coagulation Hemolysis Surveillance Thrombosis

Journal

Intensive care medicine experimental
ISSN: 2197-425X
Titre abrégé: Intensive Care Med Exp
Pays: Germany
ID NLM: 101645149

Informations de publication

Date de publication:
24 Apr 2024
Historique:
received: 05 02 2024
accepted: 17 04 2024
medline: 24 4 2024
pubmed: 24 4 2024
entrez: 24 4 2024
Statut: epublish

Résumé

The continuous exposure of blood to a non-biological surface during extracorporeal membrane oxygenation (ECMO) may lead to progressive thrombus formation in the oxygenator, hemolysis and consequently impaired gas exchange. In most centers oxygenator performance is monitored only on a once daily basis. Carboxyhemoglobin (COHb) is generated upon red cell lysis and is routinely measured with any co-oximetry performed to surveille gas exchange and acid-base homeostasis every couple of hours. This retrospective cohort study aims to evaluate COHb in the arterial blood gas as a novel marker of oxygenator dysfunction and its predictive value for imminent oxygenator change. Out of the 484 screened patients on ECMO 89, cumulatively requiring 116 oxygenator changes within 1833 patient days, including 19,692 arterial COHb measurements were analyzed. Higher COHb levels were associated with lower post-oxygenator pO COHb correlates with oxygenator performance and can be predictive of imminent oxygenator change. Therefore, longitudinal measurements of COHb in clinical routine might be a cheap and more granular candidate for ECMO surveillance that should be further analyzed in a controlled prospective trial design.

Sections du résumé

BACKGROUND BACKGROUND
The continuous exposure of blood to a non-biological surface during extracorporeal membrane oxygenation (ECMO) may lead to progressive thrombus formation in the oxygenator, hemolysis and consequently impaired gas exchange. In most centers oxygenator performance is monitored only on a once daily basis. Carboxyhemoglobin (COHb) is generated upon red cell lysis and is routinely measured with any co-oximetry performed to surveille gas exchange and acid-base homeostasis every couple of hours. This retrospective cohort study aims to evaluate COHb in the arterial blood gas as a novel marker of oxygenator dysfunction and its predictive value for imminent oxygenator change.
RESULTS RESULTS
Out of the 484 screened patients on ECMO 89, cumulatively requiring 116 oxygenator changes within 1833 patient days, including 19,692 arterial COHb measurements were analyzed. Higher COHb levels were associated with lower post-oxygenator pO
CONCLUSION CONCLUSIONS
COHb correlates with oxygenator performance and can be predictive of imminent oxygenator change. Therefore, longitudinal measurements of COHb in clinical routine might be a cheap and more granular candidate for ECMO surveillance that should be further analyzed in a controlled prospective trial design.

Identifiants

pubmed: 38656714
doi: 10.1186/s40635-024-00626-7
pii: 10.1186/s40635-024-00626-7
doi:

Types de publication

Journal Article

Langues

eng

Pagination

41

Investigateurs

Eva-Maria Kleinert (EM)
Daniel Andrea Hofmaenner (DA)
Mattia M Müller (MM)
Christoph Camille Ganter (CC)
Tobias Welte (T)
Thorben Pape (T)
Ann-Kathrin Rath (AK)
Bahar Nalbant (B)
Jannik Ruwisch (J)
Christian Putensen (C)
Konrad Peukert (K)
Andrea Sauer (A)
Lennart Wild (L)

Informations de copyright

© 2024. The Author(s).

Références

Raasveld SJ, Volleman C, Combes A, Broman LM, Taccone FS, Peters E et al (2022) Knowledge gaps and research priorities in adult veno-arterial extracorporeal membrane oxygenation: a scoping review. Intensive Care Med Exp 10(1):50
doi: 10.1186/s40635-022-00478-z pubmed: 36424482 pmcid: 9691798
Extracorporeal Life Support Organization (ELSO). General Guidelines for all ECLS Cases—Version 1.4. 2017. https://www.elso.org/portals/0/elso%20guidelines%20general%20all%20ecls%20version%201_4.pdf . Accessed 10 May 2023.
Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C et al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 378(21):1965–1975
doi: 10.1056/NEJMoa1800385 pubmed: 29791822
Vasques F, Sanderson B, Correa G, Collins P, Camarda V, Giosa L et al (2023) Prevalence and indications for oxygenator circuit replacement in patients receiving venovenous extracorporeal membrane oxygenation. ASAIO J. https://doi.org/10.1097/MAT.0000000000001977
doi: 10.1097/MAT.0000000000001977 pubmed: 37159512
Lubnow M, Philipp A, Foltan M, Enger TB, Lunz D, Bein T et al (2014) Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange – retrospective analysis of 265 cases. PLoS ONE 9(12):e112316
doi: 10.1371/journal.pone.0112316 pubmed: 25464516 pmcid: 4251903
Hoffman KR, Diehl A, Paul E, Burrell AJC (2023) The hematological effects of extracorporeal membrane oxygenator exchange. ASAIO J. https://doi.org/10.1097/MAT.0000000000001976
doi: 10.1097/MAT.0000000000001976 pubmed: 37382896 pmcid: 10298168
Zakhary B, Vercaemst L, Mason P, Antonini MV, Lorusso R, Brodie D (2020) How I approach membrane lung dysfunction in patients receiving ECMO. Crit Care 24(1):1–4
doi: 10.1186/s13054-020-03388-2
Lubnow M, Philipp A, Dornia C, Schroll S, Bein T, Creutzenberg M et al (2014) D-Dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation. J Crit Care 29(3):473.e1-473.e5
doi: 10.1016/j.jcrc.2013.12.008 pubmed: 24508200
Appelt H, Philipp A, Mueller T, Foltan M, Lubnow M, Lunz D et al (2020) Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)-Comparison of VA- versus VV ECMO. PLoS ONE 15(1):e0227793
doi: 10.1371/journal.pone.0227793 pubmed: 31986168 pmcid: 6984694
Robak O, Grafeneder-Weissteiner T, Schellongowski P, Bojic A, Paschen C, Hermann A et al (2022) In vivo suction pressures of venous cannulas during veno-venous extracorporeal membrane oxygenation. ASAIO J 68(11):1372
doi: 10.1097/MAT.0000000000001668 pubmed: 35184088
Lehle K, Philipp A, Zeman F, Lunz D, Lubnow M, Wendel HP et al (2015) Technical-induced hemolysis in patients with respiratory failure supported with veno-venous ECMO—prevalence and risk factors. PLoS ONE 10(11):e0143527
doi: 10.1371/journal.pone.0143527 pubmed: 26606144 pmcid: 4659553
Ryter SW, Otterbein LE, Morse D, Choi AMK (2002) Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234–235(1–2):249–263
doi: 10.1023/A:1015957026924 pubmed: 12162441 pmcid: 7101540
Morse D, Choi AMK (2002) Heme oxygenase-1. Am J Respir Cell Mol Biol 27(1):8–16
doi: 10.1165/ajrcmb.27.1.4862 pubmed: 12091240
Rose JJ, Wang L, Xu Q, McTiernan CF, Shiva S, Tejero J et al (2017) Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy. Am J Respir Crit Care Med 195(5):596–606
doi: 10.1164/rccm.201606-1275CI pubmed: 27753502 pmcid: 5363978
Steuer NB, Schlanstein PC, Hannig A, Sibirtsev S, Jupke A, Schmitz-Rode T et al (2022) Extracorporeal hyperoxygenation therapy (EHT) for carbon monoxide poisoning: in-vitro proof of principle. Membranes 12(1):56
doi: 10.3390/membranes12010056
Scharte M, Bone HG, Van Aken H, Meyer J (2000) Increased carbon monoxide in exhaled air of critically ill patients. Biochem Biophys Res Commun 267(1):423–426
doi: 10.1006/bbrc.1999.1936 pubmed: 10623635
Rusca M, Oddo M, Schaller MD, Liaudet L (2004) Carboxyhemoglobin formation as an unexpected side effect of inhaled nitric oxide therapy in severe acute respiratory distress syndrome. Crit Care Med 32(12):2537
doi: 10.1097/01.CCM.0000148012.80245.FC pubmed: 15599162
Meyer J, Prien T, Van Aken H, Bone HG, Waurick R, Theilmeier G et al (1998) Arterio-venous carboxyhemoglobin difference suggests carbon monoxide production by human lungs. Biochem Biophys Res Commun 244(1):230–232
doi: 10.1006/bbrc.1998.8244 pubmed: 9514911
Hermans G, Wilmer A, Knockaert D, Meyns B (2008) Endogenous carbon monoxide production: a rare and detrimental complication of extracorporeal membrane oxygenation. ASAIO J 54(6):633–635
doi: 10.1097/MAT.0b013e318185e1e6 pubmed: 19033779
Kai Man C, Koon NL (2018) Endogenous carbon monoxide production in extracorporeal membrane oxygenation-related hemolysis: potential use of point-of-care CO-oximetry carboxyhemoglobin to detect hemolysis. Clin Case Rep 6(2):346–349
doi: 10.1002/ccr3.1351 pubmed: 29445475 pmcid: 5799617
Burns J, Hurtado-Doce A, Lees N (2015) 146: Carboxyhemoglobin associated with hemolysis as a marker of impending oxygenator failure in VA ECMO. Crit Care Med 43:38
doi: 10.1097/01.ccm.0000473974.89362.6e
Shah N, Said AS (2021) Extracorporeal support prognostication-time to move the goal posts? Membranes (Basel) 11(7):537
doi: 10.3390/membranes11070537 pubmed: 34357187
Imura S, Gelbart B, Chiletti R, Stephens D, Butt W (2022) Carboxyhemoglobin levels in children during extracorporeal membrane oxygenation support: a retrospective study. Perfusion 37(8):797–804
doi: 10.1177/02676591211027776 pubmed: 34233534
Hoffman KR, Burrell AJC, Diehl A, Butt W (2021) Elevated carboxyhaemoglobin as a novel indicator for extracorporeal membrane haemolysis and oxygenator exchange. Crit Care 25(1):159
doi: 10.1186/s13054-021-03582-w pubmed: 33906676 pmcid: 8077716
Nisar S, Gibson CD, Sokolovic M, Shah NS (2020) Pulse oximetry is unreliable in patients on veno-venous extracorporeal membrane oxygenation caused by unrecognized carboxyhemoglobinemia. ASAIO J 66(10):1105–1109
doi: 10.1097/MAT.0000000000001144 pubmed: 33136597
Tripathi RS, Papadimos TJ (2011) ECMO and endogenous carboxyhemoglobin formation. Int J Crit Illn Inj Sci 1(2):168
doi: 10.4103/2229-5151.84809 pubmed: 22229146 pmcid: 3249854
Fazekas AS, Wewalka M, Zauner C, Funk GC (2012) Carboxyhemoglobin levels in medical intensive care patients: a retrospective, observational study. Crit Care 16(1):1–8
doi: 10.1186/cc11138
Hawla A, Ray S, Matettore A, Peters MJ (2019) Arterial carboxyhaemoglobin levels in children admitted to PICU: a retrospective observational study. PLoS ONE 14(3):e0209452
doi: 10.1371/journal.pone.0209452 pubmed: 30845230 pmcid: 6405068
Bemtgen X, Rilinger J, Holst M, Rottmann F, Lang CN, Jäckel M et al (2022) Carboxyhemoglobin (CO-Hb) correlates with hemolysis and hospital mortality in extracorporeal membrane oxygenation: a retrospective registry. Diagnostics (Basel) 12(7):1642
doi: 10.3390/diagnostics12071642 pubmed: 35885547
Pan KC, McKenzie DP, Pellegrino V, Murphy D, Butt W (2016) The meaning of a high plasma free haemoglobin: retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years. Perfusion 31(3):223–231
doi: 10.1177/0267659115595282 pubmed: 26201941
Shah N, Gibson C, Kitchen G, Hockstein M, Sokolovic M (2016) 142: Elevated carboxyhemoglobin levels in patients requiring extracorporeal membrane oxygenation. Crit Care Med 44(12):113–113
doi: 10.1097/01.ccm.0000508824.16403.98
Szabo A (1978) Kinetics of hemoglobin and transition state theory. Proc Natl Acad Sci 75(5):2108–2111
doi: 10.1073/pnas.75.5.2108 pubmed: 276856 pmcid: 392500
Hayes D, McConnell PI, Preston TJ, Nicol KK (2014) Hyperbilirubinemia complicating plasma-free hemoglobin and antifactor Xa level monitoring on venovenous extracorporeal membrane oxygenation. World J Pediatr Congenit Heart Surg 5(2):345–347
doi: 10.1177/2150135113509818 pubmed: 24668991
Hariri G, Hodjat Panah K, Beneteau-Burnat B, Chaquin M, Mekinian A, Ait-Oufella H (2021) Carboxyhemoglobin, a reliable diagnosis biomarker for hemolysis in intensive care unit: a retrospective study. Crit Care 25(1):1–3
doi: 10.1186/s13054-020-03437-w
Cousin VL, Giraud R, Assouline B, Silva IN, Bendjelid K (2022) Use of carboxyhemoglobin as an early sign of oxygenator dysfunction in patients supported by extracorporeal membrane oxygenation. Front Med 9:893642
doi: 10.3389/fmed.2022.893642

Auteurs

Rolf Erlebach (R)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Alix Buhlmann (A)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Rea Andermatt (R)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Benjamin Seeliger (B)

Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.

Klaus Stahl (K)

Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.

Christian Bode (C)

Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

Reto Schuepbach (R)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Pedro David Wendel-Garcia (PD)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Sascha David (S)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland. sascha.david@usz.ch.

Classifications MeSH